drugset / Trial / NCT02604680

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

NCT02604680 ↗

Phase 2 Completed 509 enrolled Braintree Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of the study is to compare the safety and efficacy of multiple formulations of BLI1100 to a control group and placebo in treating patients with moderate-severe acne vulgaris.

Timeline

Start
2015-10
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI1100-1 Unknown — Topical
Subject BLI1100-2 Unknown — Topical
Subject BLI1100-3 Unknown — Topical
Subject BLI1100-4 Unknown — Topical

Indications